Cyclacel Pharmaceuticals, Inc. of BERKELEY HEIGHTS, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-04. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Showing 25 of 35 people.
| Name | Role | Location |
|---|---|---|
| Samuel L Barker | Director | The Woodlands, TX |
| Christopher S Henney | Director | Berkeley Heights, NJ |
| Gregory T Hradsky | Director | Berkeley Heights, NJ |
| Brian L Schwartz | Director | Berkeley Heights, NJ |
| Lloyd T Sems | Director | Berkeley Heights, NJ |
| Robert J Speigel | Director | Berkeley Heights, NJ |
| Karin L Walker | Director | Berkeley Heights, NJ |
| Mark H Kirschbaum | Executive Officer | Berkeley Heights, NJ |
| Brian Schwartz | Director | Seattle, WA |
| Avraham Fock Ben-Tzvi | Director | Berkeley Heights, NJ |
| Kiu Cu Seng | Executive Officer | Berkeley Heights, NJ |
| David Fock Natan | Director | Berkeley Heights, NJ |
| Kwang Fock Chong | Director | Berkeley Heights, NJ |
| Datuk Dr. Doris Wong Sing Ee | Executive Officer | Berkeley Heights, NJ |
| Paul McBarron | Director | Berkeley Heights, NJ |
| Paul McBarron | Executive Officer | Berkeley Heights, NJ |
| Avraham Ben-Tzvi | Director | Berkeley Heights, NJ |
| David Natan | Director | Tsuen Wan, K3 |
| Spiro Rombotis | Director | Berkeley Heights, NJ |
| Spiro Rombotis | Executive Officer | Berkeley Heights, NJ |
| David Lazar | Executive Officer | ARLINGTON, MA |
| Samuel Barker | Director | Berkeley Heights, NJ |
| Robert Spiegel | Director | Berkeley Heights, NJ |
| Karin Walker | Director | Berkeley Heights, NJ |
| Christopher Henney | Director | Berkeley Heights, NJ |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-03-25 | D | $1.0M | $1.0M |
| 2025-02-14 | D | — | — |
| 2025-02-14 | D | $25.0M | — |
| 2024-11-26 | D | $2.1M | $2.1M |
| 2024-05-17 | D | $8.0M | $8.0M |
| 2012-05-01 | D | $3.0M | $3.0M |
| 2010-10-21 | D | $22.2M | $15.2M |